Carvedilol and Atrioventricular block second degree - a phase IV clinical study of FDA data
Summary:
Atrioventricular block second degree is reported as a side effect among people who take Carvedilol (carvedilol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Sinus tachycardia.
The phase IV clinical study analyzes which people have Atrioventricular block second degree when taking Carvedilol. It is created by eHealthMe based on reports of 110,224 people who have side effects when taking Carvedilol from the FDA, and is updated regularly.
What is Carvedilol?
Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.
What is Atrioventricular block second degree?
Atrioventricular block second degree (heart block second degree) is found to be associated with 378 drugs and 818 conditions by eHealthMe. Check the latest studies of Atrioventricular block second degree.
110,224 people reported to have side effects when taking Carvedilol.
Among them, 78 people (0.07%) have Atrioventricular block second degree.

Among these 78 people:
How long have people been on Carvedilol when they have Atrioventricular block second degree? *
- < 1 month: 37.5 %
- 1 - 6 months: 18.75 %
- 6 - 12 months: 18.75 %
- 1 - 2 years: 25.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Atrioventricular block second degree when taking Carvedilol? *
- female: 30.99 %
- male: 69.01 %
What is the age of people who have Atrioventricular block second degree when taking Carvedilol? *
- 0-1: 1.72 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 12.07 %
- 40-49: 3.45 %
- 50-59: 6.9 %
- 60+: 75.86 %
What are other drugs people take besides Carvedilol? *
- Aspirin: 12 people, 15.38%
- Furosemide: 11 people, 14.10%
- Acetaminophen: 7 people, 8.97%
- Spironolactone: 7 people, 8.97%
- Lisinopril: 7 people, 8.97%
- Digoxin: 7 people, 8.97%
- Lipitor: 6 people, 7.69%
- Acetylsalicylic Acid: 5 people, 6.41%
- Norvasc: 5 people, 6.41%
- Coreg: 5 people, 6.41%
What are other side effects people have besides Atrioventricular block second degree? *
- Bradycardia (abnormally slow heart action): 20 people, 25.64%
- Atrioventricular Block First Degree (heart block first degree): 19 people, 24.36%
- Arrhythmias (irregular heartbeat): 12 people, 15.38%
- Dizziness: 10 people, 12.82%
- Weakness: 8 people, 10.26%
- Chest Pain: 8 people, 10.26%
- Acute Kidney Failure: 7 people, 8.97%
- Atrioventricular Block Complete (heart block complete): 7 people, 8.97%
- Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 7 people, 8.97%
- Cough: 6 people, 7.69%
What are the existing conditions these people have? *
- Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 8 people, 10.26%
- Cardiac Failure Congestive: 7 people, 8.97%
- Dyslipidaemia (abnormal amount of lipids): 6 people, 7.69%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 7.69%
- High Blood Cholesterol: 6 people, 7.69%
- Abdominal Pain Upper: 4 people, 5.13%
- Cardiac Disorder: 4 people, 5.13%
- Hepatic Neoplasm Malignant (liver cancer): 4 people, 5.13%
- Pain In Extremity: 4 people, 5.13%
- Pain: 4 people, 5.13%
* Approximation only. Some reports may have incomplete information.
Do you take Carvedilol and have Atrioventricular block second degree?
- Check whether Atrioventricular block second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Carvedilol:
- Carvedilol (112,649 reports)
Atrioventricular block second degree treatments and more:
- Atrioventricular block second degree (4,079 reports)
How severe was Atrioventricular block second degree and when was it recovered:
Expand to all the drugs that have ingredients of carvedilol:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Carvedilol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Atrioventricular block second degree:
- Atrioventricular block second degree (378 drugs)
Browse all the conditions that are associated with Atrioventricular block second degree:
- Atrioventricular block second degree (818 conditions)
Related publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on carvedilol (the active ingredients of Carvedilol) and Carvedilol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Inflectra and Clozaril - a second ago
- Drug interactions of Cefaclor and Erythromycin Estolate - a second ago
- Could Nicorette cause Salivary Hypersecretion? - 10 seconds ago
- Drug interactions of Dorzolamide Hydrochloride And Timolol Maleate and Acetaminophen - 13 seconds ago
- Drug interactions of Wellbutrin and Diclofenac Sodium - 46 seconds ago
- Could Breo Ellipta cause Dementia? - 48 seconds ago
- Could Qsymia cause Constipation? - a minute ago
- Drug interactions of Lopurin and Innohep - a minute ago
- Drug interactions of Claritin and Abilify - a minute ago
- Drug interactions of Lopurin and Cubicin - a minute ago